Merck (MRK)
Evaluates the company's acquisition strategy in biotechnology and the expansion of its drug portfolio.
* Does not constitute investment advice
Yükleniyor...
Radar Rating
Very Good
5-dimension analyst performance assessment
Total Analyses
1000
Buy
612
Sell
184
Hold
204
Unique Assets
10
Active Days
70+
Evaluates the company's acquisition strategy in biotechnology and the expansion of its drug portfolio.
* Does not constitute investment advice
Interprets the change in the company's management team and the impact of the CEO's departure on market expectations.
* Does not constitute investment advice
The speaker examines state-level property tax exemptions and tax reduction strategies offered for property owners over the age of 65.
* Does not constitute investment advice
The Yahoo Finance team scrutinizes the general trend in global markets and daily opening data.
* Does not constitute investment advice
The speaker examines the general trend in global markets and the impact of economic data on stock indices.
* Does not constitute investment advice
The speakers examine the potential effects of rising oil prices on the inflation outlook and the Fed's interest rate policy.
* Does not constitute investment advice
The speakers analyze the March Fed meeting, interest rate expectations, and potential changes in the central bank's communication strategy.
* Does not constitute investment advice
The speaker evaluates the tentative rebound across US equity markets and analyzes the technical factors driving the recent rise in stock prices.
* Does not constitute investment advice
The speaker examines the upward trend in global markets and the impact of increased risk appetite on major indices.
* Does not constitute investment advice
The speaker analyzes the retreat in energy markets and the technical outlook forming in oil prices as geopolitical tensions ease.
* Does not constitute investment advice